BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34807348)

  • 21. Independent prognostic value of serum hepatocyte growth factor in bladder cancer.
    Gohji K; Nomi M; Niitani Y; Kitazawa S; Fujii A; Katsuoka Y; Nakajima M
    J Clin Oncol; 2000 Aug; 18(16):2963-71. PubMed ID: 10944129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study.
    Shahidi S; Hejazi J; Moghimi M; Borji S; Zabihian S; Fathi M
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2847-2851. PubMed ID: 33112539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
    Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
    Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
    Dyrskjøt L; Reinert T; Algaba F; Christensen E; Nieboer D; Hermann GG; Mogensen K; Beukers W; Marquez M; Segersten U; Høyer S; Ulhøi BP; Hartmann A; Stöhr R; Wach S; Nawroth R; Schwamborn K; Tulic C; Simic T; Junker K; Harving N; Petersen AC; Jensen JB; Keck B; Grimm MO; Horstmann M; Maurer T; Steyerberg EW; Zwarthoff EC; Real FX; Malats N; Malmström PU; Ørntoft TF
    Eur Urol; 2017 Sep; 72(3):461-469. PubMed ID: 28583312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
    Kimura S; Soria F; D'Andrea D; Foerster B; Abufaraj M; Vartolomei MD; Karakiewicz PI; Mathieu R; Moschini M; Rink M; Egawa S; Shariat SF; Gust KM
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1123-e1132. PubMed ID: 30061034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer.
    Cheng X; Liu X; Liu X; Guo Z; Sun H; Zhang M; Ji Z; Sun W
    Front Oncol; 2018; 8():494. PubMed ID: 30450336
    [No Abstract]   [Full Text] [Related]  

  • 27. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum CA 19-9 as a good prognostic biomarker in patients with bladder cancer.
    Wang QH; Ji ZG; Chen ZG; Li HZ; Fan H; Fan XR; Shi BB; Fang Y
    Int J Surg; 2015 Mar; 15():113-6. PubMed ID: 25647541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F; Chen HG; Zhang RY; Jin D; Xu SS; Wu GY; Xu JR
    Eur Radiol; 2019 Aug; 29(8):4447-4455. PubMed ID: 30666451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.
    Zhang J; Ke M; Ren Y; Bi J; Du Z; Zhang M; Wang Y; Zhang L; Wu Z; Lv Y; Wu R
    Dis Markers; 2019; 2019():9850191. PubMed ID: 31976024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
    Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
    BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer.
    Elsharkawi F; Elsabah M; Shabayek M; Khaled H
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2219-2224. PubMed ID: 31350988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Cimen HI; Halis F; Saglam HS; Gokce A
    Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
    Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
    BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating proteomic signature for detection of biomarkers in bladder cancer patients.
    Nedjadi T; Benabdelkamal H; Albarakati N; Masood A; Al-Sayyad A; Alfadda AA; Alanazi IO; Al-Ammari A; Al-Maghrabi J
    Sci Rep; 2020 Jul; 10(1):10999. PubMed ID: 32620920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
    Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of miR-100 as a novel ancillary non-invasive biomarker for early detection of bladder carcinoma.
    Qureshi A; Fahim A; Kazi N; Farsi Kazi SA; Nadeem F
    J Pak Med Assoc; 2018 May; 68(5):759-763. PubMed ID: 29885177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of irisin in patients with acute abdominal pain: A preliminary study.
    Yeniocak S; Karcıoğlu Ö; Kalkan A; Saraç F; Akgül Karadana G; Keklikkıran ZZ; Gümüş A; Koldaş M; Korkut S
    Ulus Travma Acil Cerrahi Derg; 2018 Nov; 24(6):539-544. PubMed ID: 30516253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    D'Andrea D; Soria F; Zehetmayer S; Gust KM; Korn S; Witjes JA; Shariat SF
    BJU Int; 2019 Jun; 123(6):959-967. PubMed ID: 30653818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.